BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

33 related articles for article (PubMed ID: 219588)

  • 1. Resistance to Marek's disease at hatching in chickens vaccinated as embryos with the turkey herpesvirus.
    Sharma JM; Burmester BR
    Avian Dis; 1982; 26(1):134-49. PubMed ID: 6284106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effectiveness of cell-free or cell-associated turkey herpesvirus vaccine against Marek's disease in chickens as influenced by maternal antibody, vaccine dose, and time of exposure to Marek's disease virus.
    Eidson CS; Page RK; Kleven SH
    Avian Dis; 1978; 22(4):583-97. PubMed ID: 219826
    [No Abstract]   [Full Text] [Related]  

  • 3. Precipitating antibody development in chicks experimentally infected with herpes virus of turkey and Marek's disease virus.
    Rana UV; Negi SK
    J Commun Dis; 1986 Mar; 18(1):13-6. PubMed ID: 3018071
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of maternal antibody on efficacy of embryo vaccination with cell-associated and cell-free Marek's disease vaccine.
    Sharma JM; Graham CK
    Avian Dis; 1982; 26(4):860-70. PubMed ID: 6297450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turkey herpesvirus infection in chickens: induction of lymphoproliferative lesions and characterization of vaccinal immunity against Marek's disease.
    Witter RL; Sharma JM; Offenbecker L
    Avian Dis; 1976; 20(4):676-92. PubMed ID: 186008
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Immunomorphological changes in chicks vaccinated against Marek's disease with herpesvirus Sz-1].
    Enchev S; Kasabov R
    Vet Med Nauki; 1978; 15(7):53-60. PubMed ID: 219588
    [No Abstract]   [Full Text] [Related]  

  • 7. Vaccinal control of Marek's disease: current challenges, and future strategies to maximize protection.
    Baigent SJ; Smith LP; Nair VK; Currie RJ
    Vet Immunol Immunopathol; 2006 Jul; 112(1-2):78-86. PubMed ID: 16682084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Marek's disease virus and the herpesvirus of turkeys.
    Purchase HG
    Prog Med Virol; 1974; 18(0):178-97. PubMed ID: 4371178
    [No Abstract]   [Full Text] [Related]  

  • 9. Production of Marek's disease vaccine.
    Ben-Nathan D; Lustig S
    Adv Biotechnol Processes; 1990; 14():347-65. PubMed ID: 2171556
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Turkey herpesvirus and Marek's disease virus. A comparative appraisal.
    Prasad LB
    Comp Immunol Microbiol Infect Dis; 1979; 2(2-3):335-58. PubMed ID: 228905
    [No Abstract]   [Full Text] [Related]  

  • 11. Pathogenesis of Marek's disease.
    Payne LN; Frazier JA; Powell PC
    Int Rev Exp Pathol; 1976; 16():59-154. PubMed ID: 182652
    [No Abstract]   [Full Text] [Related]  

  • 12. Study of host-pathogen interactions to identify sustainable vaccine strategies to Marek's disease.
    Baaten BJ; Butter C; Davison TF
    Vet Immunol Immunopathol; 2004 Aug; 100(3-4):165-77. PubMed ID: 15207454
    [TBL] [Abstract][Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 2.